{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:11:37Z","timestamp":1793211097314,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jns.2022.120192","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T18:06:16Z","timestamp":1645293976000},"page":"120192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["Drug-induced tremor, clinical features, diagnostic approach and management"],"prefix":"10.1016","volume":"435","author":[{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2022.120192_bb0010","doi-asserted-by":"crossref","first-page":"684835","DOI":"10.3389\/fneur.2021.684835","article-title":"Tremor syndromes: an updated review","volume":"12","author":"Lenka","year":"2021","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2022.120192_bb0015","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jnnp-2019-322676","article-title":"Systematic clinical approach for diagnosing upper limb tremor","volume":"91","author":"van de Wardt","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0020","series-title":"Drug-Induced Movement Disorders","first-page":"209","article-title":"Lithium-induced movement disorders","author":"Factor","year":"2004"},{"key":"10.1016\/j.jns.2022.120192_bb0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0278-5846(82)80162-0","article-title":"Difficulties in assessing adverse drug reactions in clinical trials","volume":"6","author":"Naranjo","year":"1982","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0030","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5334\/tohm.374","article-title":"Insights into pathophysiology from medication-induced tremor","volume":"7","author":"Morgan","year":"2017","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"7","key":"10.1016\/j.jns.2022.120192_bb0035","first-page":"552","article-title":"Adverse reactions of amiodarone","volume":"16","author":"Colunga Biancatelli","year":"2019","journal-title":"J. Geriatr. Cardiol."},{"issue":"6 Pt 2","key":"10.1016\/j.jns.2022.120192_bb0040","first-page":"138S","article-title":"Optimal management of amiodarone therapy: efficacy and side effects","volume":"18","author":"Hilleman","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0022-510X(84)90200-4","article-title":"Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study","volume":"63","author":"Pellissier","year":"1984","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2022.120192_bb0050","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archinte.1987.00370050077013","article-title":"Unusual neurotoxicity associated with amiodarone therapy","volume":"147","author":"Palakurthy","year":"1987","journal-title":"Arch. Intern. Med."},{"issue":"5","key":"10.1016\/j.jns.2022.120192_bb0055","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1212\/WNL.34.5.669","article-title":"Frequent neurologic toxicity associated with amiodarone therapy","volume":"34","author":"Charness","year":"1984","journal-title":"Neurology"},{"issue":"4 Pt 2","key":"10.1016\/j.jns.2022.120192_bb0060","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/0002-8703(83)90016-9","article-title":"Side effects and possible contraindications of amiodarone use","volume":"106","author":"Harris","year":"1983","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.jns.2022.120192_bb0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0002-9149(83)90515-5","article-title":"Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation","volume":"52","author":"Morady","year":"1983","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0070","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0735-1097(83)80338-6","article-title":"Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias","volume":"2","author":"Greene","year":"1983","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.jns.2022.120192_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00045391-200607000-00007","article-title":"Incidence rate of adverse drug reactions during long-term follow-up of patients newly treated with amiodarone","volume":"13","author":"Bongard","year":"2006","journal-title":"Am. J. Ther."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ageing\/17.2.116","article-title":"Noncardiac side-effects of long-term oral amiodarone in the elderly","volume":"17","author":"Hyatt","year":"1988","journal-title":"Age Ageing"},{"issue":"7","key":"10.1016\/j.jns.2022.120192_bb0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archneurol.2009.96","article-title":"Frequency, characteristics, and risk factors for amiodarone neurotoxicity","volume":"66","author":"Orr","year":"2009","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2022.120192_bb0090","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.amjcard.2005.06.093","article-title":"Severe ataxia caused by amiodarone","volume":"96","author":"Krauser","year":"2005","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.410250618","article-title":"Parkinsonism and amiodarone therapy","volume":"25","author":"Werner","year":"1989","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5414\/NPP29084","article-title":"Amiodarone-induced liver cirrhosis and parkinsonism: a case report","volume":"29","author":"Ishida","year":"2010","journal-title":"Clin. Neuropathol."},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0248-8663(10)80021-9","article-title":"Toxicit\u00e9 neurologique de l\u2019amiodarone. A propos de cinq observations [Neurological toxicity of amiodarone. 5 case reports]","volume":"13","author":"Arnaud","year":"1992","journal-title":"Rev. Med. Interne"},{"issue":"4","key":"10.1016\/j.jns.2022.120192_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0002-9149(86)90917-3","article-title":"Tremor induced by procainamide","volume":"57","author":"Rubinstein","year":"1986","journal-title":"Am. J. Cardiol."},{"issue":"5","key":"10.1016\/j.jns.2022.120192_bb0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/clc.4960130509","article-title":"Mexiletine: pharmacology and therapeutic use","volume":"13","author":"Manolis","year":"1990","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0120","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0149-2918(98)80056-8","article-title":"A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients","volume":"20","author":"Diaz-Martinez","year":"1998","journal-title":"Clin. Ther."},{"issue":"5","key":"10.1016\/j.jns.2022.120192_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1353-8020(01)00043-8","article-title":"Fluoxetine-induced tremor: clinical features in 21 patients","volume":"8","author":"Serrano-Due\u00f1as","year":"2002","journal-title":"Parkinsonism Relat. Disord."},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0130","first-page":"661","article-title":"Chin tremors associated with paroxetine in a patient with pancreatic adenocarcinoma","volume":"14","author":"John","year":"2013","journal-title":"JOP"},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clineuro.2004.01.008","article-title":"Citalopram-induced jaw tremor","volume":"107","author":"Tarlaci","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2003.10.035","article-title":"Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats","volume":"153","author":"Arshaduddin","year":"2004","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.jns.2022.120192_bb0145","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4088\/JCP.v57n1002","article-title":"Movement disorders associated with the serotonin selective reuptake inhibitors","volume":"57","author":"Leo","year":"1996","journal-title":"J. Clin. Psychiatr"},{"issue":"5","key":"10.1016\/j.jns.2022.120192_bb0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(98)00036-0","article-title":"Extrapyramidal adverse effects associated with sertraline","volume":"22","author":"Lambert","year":"1998","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0155","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S1461145705006358","article-title":"Discontinuation symptoms in depression and anxiety disorders","volume":"10","author":"Baldwin","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.jns.2022.120192_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000491524","article-title":"Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review","volume":"87","author":"Fava","year":"2018","journal-title":"Psychother. Psychosom."},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0165","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2215-0366(19)30032-X","article-title":"Tapering of SSRI treatment to mitigate withdrawal symptoms","volume":"6","author":"Horowitz","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0170","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2005-837806","article-title":"Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data","volume":"38","author":"Brambilla","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.70.1.78","article-title":"Amitriptyline enhances the central component of physiological tremor","volume":"70","author":"Raethjen","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/1178646919873925","article-title":"Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions","volume":"12","author":"Scotton","year":"2019","journal-title":"Int. J. Tryptophan Res."},{"issue":"9","key":"10.1016\/j.jns.2022.120192_bb0185","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/qjmed\/hcg109","article-title":"The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0190","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1503\/jpn.210001","article-title":"Serotonin syndrome: SSRIs are not the only culprit","volume":"46","author":"Garel","year":"2021","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jns.2022.120192_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.seizure.2021.06.004","article-title":"Antiepileptic drugs and serotonin syndrome- a systematic review of case series and case reports","volume":"91","author":"Prakash","year":"2021","journal-title":"Seizure"},{"issue":"19","key":"10.1016\/j.jns.2022.120192_bb0200","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1212\/WNL.0000000000002104","article-title":"Lithium therapy in Kleine-Levin syndrome: an open-label, controlled study in 130 patients","volume":"85","author":"Leu-Semenescu","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2022.120192_bb0205","first-page":"283","article-title":"Lithium tremor","volume":"56","author":"Gelenberg","year":"1995","journal-title":"J. Clin. Psychiatr"},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/acps.12171","article-title":"Lithium tremor revisited: pathophysiology and treatment","volume":"129","author":"Baek","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1054\/jocn.2001.1033","article-title":"A case of Parkinsonism due to lithium intoxication: treatment with pramipexole","volume":"9","author":"Dallocchio","year":"2002","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0220","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11845-011-0712-6","article-title":"The incidence and clinical correlates of lithium toxicity: a retrospective review","volume":"180","author":"Dennison","year":"2011","journal-title":"Ir. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10401239409148840","article-title":"Nadolol for lithium tremor in the presence of liver damage","volume":"6","author":"Dave","year":"1994","journal-title":"Ann. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0230","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jnnp.2006.100222","article-title":"Movement disorders in patients taking anticonvulsants","volume":"78","author":"Zadikoff","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.jns.2022.120192_bb0235","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.32.4.428","article-title":"Valproate tremors","volume":"32","author":"Karas","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120192_bb0240","doi-asserted-by":"crossref","first-page":"576579","DOI":"10.3389\/fneur.2020.576579","article-title":"Risk of valproic acid-related tremor: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2022.120192_bb0245","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.parkreldis.2017.09.011","article-title":"The clinical features and functional impact of valproate-induced tremor","volume":"44","author":"Alonso-Juarez","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0250","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s13760-019-01239-8","article-title":"Valproate-induced rest tremor and parkinsonism","volume":"121","author":"Baizabal-Carvallo","year":"2021","journal-title":"Acta Neurol. Belg."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0255","first-page":"177","article-title":"Clinical and surface EMG characteristics of valproate induced tremors","volume":"45","author":"Mehndiratta","year":"2005","journal-title":"Electromyogr. Clin. Neurophysiol."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0260","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/00207454.2016.1181631","article-title":"The relationship between valproate induced tremors and circulating neurotransmitters: a preliminary study","volume":"127","author":"Hamed","year":"2017","journal-title":"Int. J. Neurosci."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0265","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0013-9580.2005.36204.x","article-title":"Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate","volume":"46","author":"Rinnerthaler","year":"2005","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0270","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12311-020-01216-5","article-title":"Clinical and kinematic features of valproate-induced tremor and differences with essential tremor","volume":"20","author":"Paparella","year":"2021","journal-title":"Cerebellum"},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0275","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/ane.12953","article-title":"Distinguishing features between valproate-induced tremor and essential tremor","volume":"138","author":"Alonso-Juarez","year":"2018","journal-title":"Acta Neurol. Scand."},{"issue":"8","key":"10.1016\/j.jns.2022.120192_bb0280","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.parkreldis.2013.03.016","article-title":"Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia","volume":"19","author":"Silver","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2022.120192_bb0285","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2016.02.002","article-title":"Tremor pattern differentiates drug-induced resting tremor from Parkinson disease","volume":"25","author":"Nistic\u00f2","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jns.2022.120192_bb0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1620\/tjem.248.273","article-title":"Lamotrigine induces tremor among epilepsy patients probably via cerebellar pathways","volume":"248","author":"Kov\u00e1cs","year":"2019","journal-title":"Tohoku J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.WNF.0000220825.65393.93","article-title":"Reversible tremor, myoclonus, and fasciculations associated with topiramate use for migraine","volume":"29","author":"Alonso-Navarro","year":"2006","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0300","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/WNF.0b013e31815ce4c2","article-title":"Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration","volume":"31","author":"Oulis","year":"2008","journal-title":"Clin. Neuropharmacol."},{"issue":"14","key":"10.1016\/j.jns.2022.120192_bb0305","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2146\/ajhp090185","article-title":"Topiramate-induced myoclonus and psychosis during migraine prophylaxis","volume":"67","author":"Miller","year":"2010","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0310","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/bc.bc_57_19","article-title":"Pregabalin-associated movement disorders: a literature review","volume":"6","author":"Rissardo","year":"2020","journal-title":"Brain Circ."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0315","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0091-6749(05)80071-5","article-title":"The effect of albuterol aerosol on fine-motor performance in children with chronic asthma","volume":"86","author":"Mazer","year":"1990","journal-title":"J. Allergy Clin. Immunol."},{"issue":"12","key":"10.1016\/j.jns.2022.120192_bb0320","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(05)70250-7","article-title":"Drug-induced tremors","volume":"4","author":"Morgan","year":"2005","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.jns.2022.120192_bb0325","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.rmed.2004.02.024","article-title":"Tremor side effects of salbutamol, quantified by a laser pointer technique","volume":"98","author":"Nizet","year":"2004","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.jns.2022.120192_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049088","article-title":"Beta-adrenergic modulation of tremor and corticomuscular coherence in humans","volume":"7","author":"Baker","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0335","first-page":"65P","article-title":"Evidence for a direct peripheral effect of adrenaline on physiological tremor in man","volume":"189","author":"Foley","year":"1967","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1474-4422(19)30400-4","article-title":"\u03b2-adrenoreceptors and the risk of Parkinson\u2019s disease","volume":"19","author":"Hopfner","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2022.120192_bb0345","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.40.5.741","article-title":"Movement disorders in alcoholism: a review","volume":"40","author":"Neiman","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120192_bb0350","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.35.11.1660","article-title":"Tremor in chronic alcoholism","volume":"35","author":"Koller","year":"1985","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.jns.2022.120192_bb0355","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/mds.22599","article-title":"Substance abuse and movement disorders","volume":"25","author":"Brust","year":"2010","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2022.120192_bb0360","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1369-1600.2006.00017.x","article-title":"Movement disorders and alcohol misuse","volume":"11","author":"Hess","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.jns.2022.120192_bb0365","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2125.1980.tb00505.x","article-title":"Finger tremor and cigarette smoking","volume":"10","author":"Lippold","year":"1980","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2022.120192_bb0370","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/clpt.1983.109","article-title":"Effects of cigarette smoking and oral nicotine on hand tremor","volume":"33","author":"Shiffman","year":"1983","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jns.2022.120192_bb0375","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fneur.2015.00075","article-title":"Psychostimulants and movement disorders","volume":"6","author":"Asser","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2022.120192_bb0380","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00002826-199619020-00004","article-title":"Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome","volume":"19","author":"Demirkiran","year":"1996","journal-title":"Clin. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.jns.2022.120192_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052025","article-title":"Illicit stimulant use in humans is associated with a long-term increase in tremor","volume":"7","author":"Flavel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2022.120192_bb0390","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mds.10623","article-title":"Rapidly progressive parkinsonism in a self-reported user of ecstasy and other drugs","volume":"18","author":"O\u2019Suilleabhain","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2022.120192_bb0395","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1212\/WNL.44.4.751","article-title":"Cocaine-induced choreoathetoid movements (\u2018crack dancing\u2019)","volume":"44","author":"Daras","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120192_bb0400","first-page":"66","article-title":"Psychomotor and electroencephalographic sequelae of cocaine dependence","volume":"163","author":"Bauer","year":"1996","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.jns.2022.120192_bb0405","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00004583-199309000-00028","article-title":"Side effects of methylphenidate and desipramine alone and in combination in children","volume":"32","author":"Pataki","year":"1993","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0410","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2001-13120","article-title":"Movement disorders induced by dopamine blocking agents","volume":"21","author":"Sethi","year":"2001","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jns.2022.120192_bb0415","series-title":"Drug-Induced Movement Disorders","first-page":"61","article-title":"Drug-induced parkinsonism","author":"Chaudhuri","year":"2004"},{"key":"10.1016\/j.jns.2022.120192_bb0420","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1988.01800250087012","article-title":"Central D2-dopaminereceptor occupancy in schizophrenic patients treated with antipsychotic drugs","volume":"45","author":"Farde","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0425","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/jnp.2.1.64","article-title":"Asymmetry in clinical features of druginduced parkinsonism","volume":"2","author":"Sethi","year":"1990","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jns.2022.120192_bb0430","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/00207454.2012.732976","article-title":"Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson\u2019s disease?","volume":"123","author":"Lim","year":"2013","journal-title":"Int. J. Neurosci."},{"issue":"15 Supplement","key":"10.1016\/j.jns.2022.120192_bb0435","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/WNL.94.15_supplement.1183","article-title":"Parkinsonism secondary to use of valbenazine and reversal with the addition of levodopa: a case report","volume":"94","author":"Vasireddy","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120192_bb0440","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mds.870070110","article-title":"Tardive tremor","volume":"7","author":"Stacy","year":"1992","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2022.120192_bb0445","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/mds.10227","article-title":"Tardive tremor due to metoclopramide","volume":"17","author":"Tarsy","year":"2002","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0450","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNF.0000000000000061","article-title":"Tetrabenazine for tardive tremor in elderly adults: a prospective follow-up study","volume":"38","author":"Kertesz","year":"2015","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2022.120192_bb0455","first-page":"119","article-title":"Metoclopramide\u2014a cholinomimetic tremorogen?","volume":"30","author":"Acharya","year":"1982","journal-title":"J. Assoc. Physicians India"},{"issue":"1","key":"10.1016\/j.jns.2022.120192_bb0460","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/jnnp.44.1.94","article-title":"Cimetidine induced postural and action tremor","volume":"44","author":"Bateman","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0465","first-page":"549","article-title":"Acute misoprostol toxicity","volume":"20","author":"Graber","year":"1991","journal-title":"Emerg Med"},{"key":"10.1016\/j.jns.2022.120192_bb0470","first-page":"877","article-title":"20 cases of acute encephalopathy with myoclonus during treatments with orally administered bismuth salts","volume":"125","author":"Buge","year":"1974","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.jns.2022.120192_bb0475","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/mds.870100215","article-title":"Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus","volume":"10","author":"Gordon","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2022.120192_bb0480","first-page":"153","article-title":"Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy","volume":"133","author":"Escourelle","year":"1977","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jns.2022.120192_bb0485","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2022.120192_bb0490","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00007890-199302000-00011","article-title":"Experience with FK506 in living-related liver transplantation","volume":"55","author":"Uemoto","year":"1993","journal-title":"Transplantation"},{"key":"10.1016\/j.jns.2022.120192_bb0495","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/ana.410350422","article-title":"FK 506-induced neurotoxicity in liver transplantation","volume":"35","author":"Wijdicks","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2022.120192_bb0500","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/rheumatology\/keh155","article-title":"Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience","volume":"43","author":"Yocum","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.jns.2022.120192_bb0505","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ctr.12581","article-title":"Switching STudy of kidney TRansplant PAtients with tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study","volume":"29","author":"Langone","year":"2015","journal-title":"Clin. Transpl."},{"key":"10.1016\/j.jns.2022.120192_bb0510","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<482::AID-CNCR17>3.0.CO;2-S","article-title":"Neurotoxicity of interferon alpha in melanoma therapy: results from a randomized controlled trial","volume":"83","author":"Caraceni","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jns.2022.120192_bb0515","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/01.WNL.0000090041.02085.22","article-title":"\u201cMyorhythmia\u201d slow facial tremor from chronic interferon alpha-2a usage","volume":"61","author":"Tan","year":"2003","journal-title":"Neurology"},{"issue":"48","key":"10.1016\/j.jns.2022.120192_bb0520","first-page":"57","article-title":"Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia","volume":"61","author":"Sarasombath","year":"2002","journal-title":"Hawaii Med. J."},{"issue":"7","key":"10.1016\/j.jns.2022.120192_bb0525","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jnnp-2020-323055","article-title":"Central nervous system complications associated with immune checkpoint inhibitors","volume":"91","author":"Vogrig","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120192_bb0530","first-page":"120014","article-title":"Parkinsonism in viral, paraneoplastic, and autoimmune diseases","volume":"1","author":"Xing","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120192_bb0535","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13104-015-1283-9","article-title":"Steroid responsive encephalopathy associated with autoimmune thyroiditis following ipilimumab therapy: a case report","volume":"8","author":"Carl","year":"2015","journal-title":"BMC Res. Notes"},{"issue":"6","key":"10.1016\/j.jns.2022.120192_bb0540","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000604","article-title":"Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors","volume":"6","author":"Vogrig","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"24","key":"10.1016\/j.jns.2022.120192_bb0545","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.2169\/internalmedicine.3200-19","article-title":"Steroid-responsive nivolumab-induced involuntary movement with anti-thyroid antibodies","volume":"58","author":"Maetani","year":"2019","journal-title":"Intern. Med."},{"key":"10.1016\/j.jns.2022.120192_bb0550","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/pgmj.56.655.346","article-title":"Pindolol-induced tremor","volume":"56","author":"Hod","year":"1980","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jns.2022.120192_bb0555","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00002826-198710000-00007","article-title":"Pindolol-induced tremor","volume":"10","author":"Koller","year":"1987","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2022.120192_bb0560","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1212\/WNL.27.5.439","article-title":"Comparison between the effects of pindolol and propranolol on essential tremor","volume":"27","author":"Teravainen","year":"1977","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120192_bb0565","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jama.1981.03310310043020","article-title":"Amphetamine-like reactions to phenylpropanolamine","volume":"245","author":"Dietz","year":"1981","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2022.120192_bb0570","first-page":"722","article-title":"A comparative study of the side effects between pseudoephedrine in loratadine plus pseudoephedrine sulfate repetabs tablets and loratadine + pseudoephedrine tablet in treatment of allergic rhinitis in Thai patients","volume":"85","author":"Supiyaphun","year":"2002","journal-title":"J. Med. Assoc. Thail."},{"key":"10.1016\/j.jns.2022.120192_bb0575","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0022-510X(95)00128-O","article-title":"Efficacy of an adenosine antagonist, theophylline, in essential tremor: comparison with placebo and propranolol","volume":"132","author":"Mally","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120192_bb0580","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.37.1.169","article-title":"Caffeine and tremor","volume":"37","author":"Koller","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2022.120192_bb0585","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00547366","article-title":"The influence of fasting and of caffeine intake on finger tremor","volume":"29","author":"Wharrad","year":"1985","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2022.120192_bb0590","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1681.1998.tb02190.x","article-title":"Caffeine, but not time of day, increases whole-arm physiological tremor in non-smoking moderate users","volume":"25","author":"Miller","year":"1998","journal-title":"Clin. Exp. Pharmacol. Physiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:58:57Z","timestamp":1758383937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":118,"alternative-id":["S0022510X22000545"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120192","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced tremor, clinical features, diagnostic approach and management","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120192"}}